Sec Form 3 Filing - Haluska Frank @ Anchiano Therapeutics Ltd. - 2020-01-01

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Haluska Frank 2. Issuer Name and Ticker or Trading Symbol Anchiano Therapeutics Ltd. [ ANCN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) C/O ANCHIANO THERAPEUTICS LTD., 5 KIRYAT HAMADA ST., P.O. BOX 45032 3. Date of Earliest Transaction (MM/DD/YY) 01/01/2020 (Street) JERUSALEM, L39777401 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price American Depository Shares ( 1 ) 5,206 D Ordinary Shares 36,082 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Investor warrants $ 1.932 06/29/2018 06/29/2023 Ordinary Shares 47,931 D Employee stock options $ 2.6 ( 2 ) 12/18/2026 Ordinary Shares 562,782 D Employee stock options $ 2.9 ( 2 ) 05/10/2027 Ordinary Shares 143,458 D Employee stock options $ 2.9 ( 2 ) 07/19/2027 Ordinary Shares 21,484 D Employee stock options $ 3.67 ( 2 ) 06/28/2028 Ordinary Shares 909,203 D Employee stock options $ 1.03 ( 3 ) 05/20/2029 Ordinary Shares 422,090 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Haluska Frank C/O ANCHIANO THERAPEUTICS LTD. 5 KIRYAT HAMADA ST., P.O. BOX 45032 JERUSALEM, L39777401 X Chief Executive Officer Signatures /s/ Frank G. Haluska 01/02/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Each American Depositary Share represents five ordinary shares, no par value per share, of the Issuer; the American Depositary Shares may be represented by American Depositary Receipts. ( 2 )1/4 of the options vest each year following the commencement of the officer's employment on May 9, 2016. ( 3 )1/16 of the options vest at the end of each calendar quarter until fully vested, beginning on May 21, 2019.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.